Time of event
According to the World Health Organization Director-General’s 2018 Report on Addressing of, and Access to, Medicines and Vaccines, access to safe, effective, quality, and affordable medicines and vaccines is an essential element of universal health coverage (UHC), and an integral part of Sustainable Development Goal 3 concerning Good Health and Well Being. The report underscores that local production of medicines and vaccines has become a means by which some developing countries are attempting to achieve greater access and health security. It also calls for the alignment of countries’ development agendas through health plans that increase local production as well as understanding of the conditions under which this approach could lead to improved access.
While the People's Republic of China and India have become large-scale global manufacturers of medicines, regionally, several countries in South and Southeast Asia have likewise established robust local pharmaceutical manufacturing sectors that support domestic health needs. Manufacturers in Indonesia, Viet Nam, Thailand, Bangladesh, and the Philippines, for example, supply many generic pharmaceuticals on their respective essential medicines lists to local people. While some firms from these countries have been quite successful at manufacturing relatively simple generic treatments, there is a clear need to upgrade their capacities to advance universal access, as envisaged under the Sustainable Development Goals and the ADB Strategy 2030’s Priority on Addressing Remaining Poverty and Reducing Inequalities.
The purpose of this sub-regional workshop is to equip government decision-makers with an understanding of coherent policies that underpin investment and technology transfer needed to upgrade domestic pharmaceutical manufacturers in the sub-region, in line with national and regional public health priorities.
- To instill government officials in ADB developing member countries with knowledge of coherent policies that underpin investment and technology transfer needed to upgrade domestic pharmaceutical manufacturers in the sub-region, in line with national and regional public health priorities.
- To promote UHC based on lessons for broadening access to safe, effective, quality, and affordable medicines.
- 16 government officials from Bangladesh, Cambodia, Indonesia, Lao PDR, Myanmar, Philippines, Sri Lanka, and Viet Nam
- ADB, ADBI, and UNCTAD staff, pharmaceutical and universal health coverage experts, and industry stakeholders
- Promotion of good governance policies and practices in the pharmaceutical sector, particularly on issues related to:
- Promotion of UHC in the region
- Design of appropriate policy framework for investment in local pharmaceutical sector
- Design of procurement policies to benefit pharmaceutical manufacturing capacities and to improve UHC
- Promotion of capital and financial market development through knowledge sharing among policymakers and practitioners in the region.
- Summary of the outcomes of the workshop, including uploading of relevant presentations and other materials on the ADBI website.
How to register
By invitation only
International Health Policy Program (IHPP), Thailand Ministry of Public Health, and United Nations Conference on Trade and Development (UNCTAD)